Johnson & Johnson (JNJ)

NYQ – Real vaqt narxi. Valyuta: USD

260.77

+0.98 (0.38%)

Bozor ochiq: Aug 12, 2026, 2:53 PM EDT

260.00

+0.20 (0.08%)

Oldingi bozordan keyin: Aug 11, 2026, 7:59 PM EDT

12.08.2026

The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is

The iShares Core High Dividend ETF (NYSEARCA:HDV) leans hard on two sectors to fund its payout.

11.08.2026

Johnson & Johnson Nearing 52-Week High: Buy, Sell or Hold?

At $261.81, Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is a hold.

11.08.2026

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

J&J's growth, new drug launches and pipeline strength support the stock, despite patent, MedTech and legal headwinds.

10.08.2026

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will.

10.08.2026

3 Beaten-Down Healthcare Stocks to Buy in August

Year to date, the healthcare sector finds itself in the middle of the S&P 500's pack.

09.08.2026

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.

Few companies have a longer track record of uninterrupted dividend growth. This streak is likely to be prolonged well into the foreseeable future.

08.08.2026

Why PG, JNJ, and KO Could Surprise Investors Next Year

Defensive blue chips rarely dominate headlines, but heading into 2027, three of the market's most reliable dividend payers stand out as durable compounders.

Videolar

02.08.2026

Positive

Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Press-relizlar

04.08.2026

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available ap.

04.08.2026

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine following a distinguished career and over 21-year tenure at Johnson & Johnson. Under her leadership, the Company's Innovative Medicine business grew to more than $60 billion in annual revenue and strengthened its position as one of the most respected and successful pharmaceutical busin.

Johnson & Johnson (JNJ)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Johnson & Johnson (JNJ)

The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is

Johnson & Johnson Nearing 52-Week High: Buy, Sell or Hold?

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

3 Beaten-Down Healthcare Stocks to Buy in August

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.

Why PG, JNJ, and KO Could Surprise Investors Next Year

Videolar

Press-relizlar

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is

Johnson & Johnson Nearing 52-Week High: Buy, Sell or Hold?

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

3 Beaten-Down Healthcare Stocks to Buy in August

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.

Why PG, JNJ, and KO Could Surprise Investors Next Year

Videolar

Press-relizlar

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

Search stocks

Johnson & Johnson (JNJ)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Johnson & Johnson (JNJ)

The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is

Johnson & Johnson Nearing 52-Week High: Buy, Sell or Hold?

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

3 Beaten-Down Healthcare Stocks to Buy in August

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.

Why PG, JNJ, and KO Could Surprise Investors Next Year

Videolar

Press-relizlar

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is

Johnson & Johnson Nearing 52-Week High: Buy, Sell or Hold?

J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

3 Beaten-Down Healthcare Stocks to Buy in August

Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.

Why PG, JNJ, and KO Could Surprise Investors Next Year

Videolar

Press-relizlar

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September